Sustained Low Clinical Event Rates in Real-World Patients Receiving Everolimus-Eluting Coronary Stent System from a Large, Prospective, Condition of Approval Study: 2-Year Clinical Outcomes from the XIENCE V® USA Study.
| Autor: | HERMILLER, JAMES B.1, RUTLEDGE, DAVID R.2, GRUBERG, LUIS3, KATOPODIS, JOHN N.4, LOMBARDI, WILLIAM5, MAO, VIVIAN W.2, ZHAO, WEIYING2, SHARMA, SAMIN K.6, TAMBOLI, HOSHEDAR P.7, WANG, JIN2, JONNAVITHULA, LALITHA2, SUDHIR, KRISHNANKUTTY2, KRUCOFF, MITCHELL W.8 |
|---|---|
| Zdroj: | Journal of Interventional Cardiology. Dec2012, Vol. 25 Issue 6, p565-575. 11p. 6 Charts, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|